Today I bring a news about two medications that we so far knew for use in type 2 diabetes: the semaglutida and the tirzepatida .
Although these drugs are approved for type 2 diabetes and weight loss, new research proposes that they could also be effective in people with type 1 diabetes (T1D) who live overweight or obesity.
These medications, which help control blood sugar in type 2 diabetes, are being increasingly prescribed to people with T1D who have difficulty controlling their glucose due to insulin resistance, a common problem in overweight people.
According to Dr. Janet Snell-Bergeon, leader of the study, these medications could offer great benefits to patients with type 1 diabetes, although there are still few data on their effectiveness in this group.
The study reviewed the medical records of 100 adults with T1D that took semaglutida or tirzepatida, and the results were quite encouraging.
Those who took these medications experienced significant weight loss compared to controls (people who did not take these drugs).In addition, its blood sugar control improved similarly between the two groups.
- 77 % of those who took semaglutida and 93 % of those who took tirzepatida ** lost at least 5 % of their body weight **.
- 47 % of semaglutida users and 87 % of those of Tirzepatida ** lost at least 10 % of their weight **.
In addition, patients who took Tirzepatida reduced their need for insulin by 18 % on average, indicating that they improved their insulin resistance.
Although the results are very promising, Dr. Snell-Bergeon emphasizes that larger studies are still needed to confirm the safety and effectiveness of these medications in people with type 1 diabetes.
But without a doubt, these results suggest that the semaglutida and the tirzepatida could be an additional complement to the treatment of T1D, especially for those who fight with weight control.
What do you think of these advances?
Greetings,
Source: [EASD] (https:/5